We also observed increased IL-6 expression in BC CML PB MNCs compared to CP CML PB MNCs or normal PB MNCs (Supplementary Fig. 12i). The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.